JP2001515353A5 - - Google Patents

Download PDF

Info

Publication number
JP2001515353A5
JP2001515353A5 JP1998538854A JP53885498A JP2001515353A5 JP 2001515353 A5 JP2001515353 A5 JP 2001515353A5 JP 1998538854 A JP1998538854 A JP 1998538854A JP 53885498 A JP53885498 A JP 53885498A JP 2001515353 A5 JP2001515353 A5 JP 2001515353A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998538854A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001515353A (ja
JP4094679B2 (ja
Filing date
Publication date
Priority claimed from US08/811,566 external-priority patent/US6127116A/en
Application filed filed Critical
Publication of JP2001515353A publication Critical patent/JP2001515353A/ja
Publication of JP2001515353A5 publication Critical patent/JP2001515353A5/ja
Application granted granted Critical
Publication of JP4094679B2 publication Critical patent/JP4094679B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP53885498A 1997-03-04 1998-02-26 Ｃ型肝炎ウイルス（ｈｃｖ）用の機能性ｄｎａクローン及びその使用 Expired - Lifetime JP4094679B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/811,566 1997-03-04
US08/811,566 US6127116A (en) 1995-08-29 1997-03-04 Functional DNA clone for hepatitis C virus (HCV) and uses thereof
PCT/US1998/004428 WO1998039031A1 (en) 1997-03-04 1998-02-26 Functional dna clone for hepatitis c virus (hcv) and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2007339488A Division JP4223068B2 (ja) 1997-03-04 2007-12-28 Ｃ型肝炎ウイルス（ｈｃｖ）用の機能性ｄｎａクローン及びその使用

Publications (3)

Publication Number Publication Date
JP2001515353A JP2001515353A (ja) 2001-09-18
JP2001515353A5 true JP2001515353A5 (enExample) 2007-05-10
JP4094679B2 JP4094679B2 (ja) 2008-06-04

Family

ID=25206905

Family Applications (2)

Application Number Title Priority Date Filing Date
JP53885498A Expired - Lifetime JP4094679B2 (ja) 1997-03-04 1998-02-26 Ｃ型肝炎ウイルス（ｈｃｖ）用の機能性ｄｎａクローン及びその使用
JP2007339488A Expired - Lifetime JP4223068B2 (ja) 1997-03-04 2007-12-28 Ｃ型肝炎ウイルス（ｈｃｖ）用の機能性ｄｎａクローン及びその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2007339488A Expired - Lifetime JP4223068B2 (ja) 1997-03-04 2007-12-28 Ｃ型肝炎ウイルス（ｈｃｖ）用の機能性ｄｎａクローン及びその使用

Country Status (9)

Country Link
US (4) US6127116A (enExample)
EP (1) EP1005366A4 (enExample)
JP (2) JP4094679B2 (enExample)
AU (1) AU742175B2 (enExample)
BR (1) BR9808147A (enExample)
CA (1) CA2283464C (enExample)
IL (2) IL131688A0 (enExample)
WO (1) WO1998039031A1 (enExample)
ZA (1) ZA981838B (enExample)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7235394B1 (en) 1995-08-29 2007-06-26 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US6242187B1 (en) * 1996-01-29 2001-06-05 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
US7338759B1 (en) 1997-03-04 2008-03-04 Washington University HCV variants
US6153421A (en) * 1997-07-18 2000-11-28 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Cloned genomes of infectious hepatitis C viruses and uses thereof
US20020034732A1 (en) * 1997-07-30 2002-03-21 Daniel J. Capon Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
US20030028011A1 (en) * 1997-07-30 2003-02-06 Parkin Neil T. Compositions and methods for determining susceptibility of hepatitis C virus to anti-viral drugs
US6893866B1 (en) * 1997-11-28 2005-05-17 The Crown In The Right Of The Queensland Department Of Health Flavivirus expression and delivery system
DE19915178A1 (de) * 1999-04-03 2000-10-05 Univ Mainz Johannes Gutenberg Hepatitis C Virus Zellkultursystem
EP1377554A1 (en) 1999-06-16 2004-01-07 University Of Iowa Research Foundation Antagonism of immunostimulatory cpg-oligonucleotides by 4-aminoquinolines and other weak bases
ES2306670T3 (es) * 1999-10-22 2008-11-16 Sanofi Pasteur Limited Procedimiento de induccion y/o intensificacion de la respuesta inmunitaria frente a antigenos tumorales.
DE19953854C2 (de) * 1999-11-09 2002-01-17 Max Planck Gesellschaft Verfahren zur Herstellung von Biopolymeren mit veränderten Eigenschaften
EP1233976A4 (en) * 1999-11-17 2003-06-11 Jiuping Ji SIMULTANEOUS DETECTION OF HBV, HCV AND HIV IN PLASMA SAMPLES WITH THE AID OF A MULTIPLEX FIXING TEST
US6921634B2 (en) * 1999-12-23 2005-07-26 Board Of Regents, The University Of Texas System Replication competent hepatitus C virus and methods of use
WO2001083736A2 (en) * 2000-04-21 2001-11-08 Boehringer Ingelheim (Canada) Ltd. Internal de novo initiation sites of the hcv ns5b polymerase and use thereof
ATE513913T1 (de) * 2000-05-10 2011-07-15 Sanofi Pasteur Ltd Durch mage minigene kodierte immunogene polypeptide und ihre verwendungen
US6447994B1 (en) 2000-06-20 2002-09-10 The General Hospital Corporation Production of replicative hepatitis C virus
EP1327687A4 (en) * 2000-10-03 2004-08-11 Tokyo Metropolitan Org Med Res METHODS OF HEPATITIS C VIRUS INFECTION
WO2002038793A2 (en) * 2000-11-07 2002-05-16 Anadys Pharmaceuticals, Inc. Hepatitis c virus constructs characterized by high efficiency replication
US20040005549A1 (en) * 2000-11-07 2004-01-08 Anadys Pharmaceuticals, Inc. Hepatitis C virus constructs characterized by high efficiency replication
ES2287074T3 (es) 2000-12-22 2007-12-16 Boehringer Ingelheim (Canada) Ltd. Molecula de rna autorreplicante del virus de la hepatitis c.
EP1381673B1 (en) * 2001-03-27 2009-05-13 Vertex Pharmaceuticals Incorporated Compositions and methods useful for hcv infection
FR2824072B1 (fr) * 2001-04-27 2004-03-12 Centre Nat Rech Scient Procede de replication et de production du virus de l'hepatite c
WO2002090572A2 (en) * 2001-05-09 2002-11-14 Third Wave Technologies, Inc. Nucleic acid detection in pooled samples
US7871814B2 (en) * 2001-05-10 2011-01-18 The Regents Of The University Of California Recombinant bicistronic flaviviruses and methods of use thereof
US20060211642A1 (en) * 2001-05-18 2006-09-21 Sirna Therapeutics, Inc. RNA inteference mediated inhibition of hepatitis C virus (HVC) gene expression using short interfering nucleic acid (siNA)
US20040209831A1 (en) * 2002-02-20 2004-10-21 Mcswiggen James RNA interference mediated inhibition of hepatitis C virus (HCV) gene expression using short interfering nucleic acid (siNA)
US20050209180A1 (en) * 2001-05-18 2005-09-22 Sirna Therapeutics, Inc. RNA interference mediated inhibition of hepatitis C virus (HCV) expression using short interfering nucleic acid (siNA)
EP1424390A4 (en) * 2001-08-06 2004-12-15 Yangling Daiying Biolog Engine INTAKE HEPATITIS-C VIRUS AND METHOD FOR ITS CULTURE IN AN IN VITRO CELL CULTURE
DK1436397T3 (da) * 2001-10-11 2010-08-09 Merck Sharp & Dohme Hepatitis C virus vaccine
US6689559B2 (en) * 2001-11-29 2004-02-10 The Research Foundation Of The State University Of New York Efficient hepatitis C virus replicon and its use in identifying antiviral compounds
ATE556084T1 (de) * 2002-03-11 2012-05-15 Lab 21 Ltd Verfahren und zusammensetzungen zur identifizierung und charakterisierung von hepatitis c
KR100471946B1 (ko) * 2002-05-08 2005-03-08 (주)팬바이오넷 Ｃ형 간염바이러스(ｈｃｖ)의 리플리콘, 이를 포함하는세포주, 및 상기 세포주를 이용한 ｈｃｖ 탐지방법
WO2004005524A1 (en) * 2002-07-02 2004-01-15 Merck & Co., Inc. Hepatitis c virus particle formation
GB0222824D0 (en) 2002-10-02 2002-11-06 Moredun Res Inst Bacteriophage-mediated immunisation II
EP2977470B1 (en) * 2002-10-16 2018-01-03 Gen-Probe Incorporated Compositions and methods for detecting west nile virus
US7927840B2 (en) 2006-09-11 2011-04-19 Gen Probe Incorporated Method for detecting West Nile Virus nucleic acids in the 3′ non-coding region
EP1556082A1 (en) * 2002-10-22 2005-07-27 Aventis Pasteur Limited Anti-cancer vaccines and high-dose cytokines as adjuvants
WO2004044182A2 (en) * 2002-11-13 2004-05-27 Washington University Highly permissive cell lines for hepatitis c virus replication
EP1694694B1 (en) 2003-12-01 2013-01-23 Board Of Regents, The University Of Texas System Replication competent hepatitis c virus and methods of use
AU2004295702A1 (en) * 2003-12-01 2005-06-16 Vertex Pharmaceuticals Incorporated Compositions comprising fetal liver cells and methods useful for HCV infection
US20060003343A1 (en) * 2004-01-23 2006-01-05 Biomerieux, Inc. Primer and probe design for efficient amplification and detection of HCV 3' non-translating region
CA2557790A1 (en) 2004-03-02 2005-09-15 Virco Bvba Estimation of clinical cut-offs
KR101246862B1 (ko) 2004-03-05 2013-03-27 베니텍 리미티드 ＲＮＡｉ 제제의 동시 전달을 위한 다중 프로모터 발현카세트
US7833987B2 (en) * 2004-03-12 2010-11-16 Indian Institute Of Science Small synthetic RNA, a method of preparing the same and uses thereof
KR20070051257A (ko) * 2004-06-21 2007-05-17 프로겐라 인코포레이티드 단백질 가수분해 활성과 관련된 진단과 스크리닝 방법 및키트
US7785875B2 (en) 2004-07-03 2010-08-31 Mogam Biotechnology Research Institute Polynucleotide encoding HCV epitopes which can bind to various HLA supertypes, immunogenic composition comprising same and method of inducing an HCV-specific immune response using same
JP4980915B2 (ja) * 2004-09-29 2012-07-18 ザ アドミニストレイターズ オブ ザ テューレイン エデュケイショナル ファンド Ｃ型肝炎ウイルスのインヒビター
US20080152633A1 (en) * 2005-02-16 2008-06-26 The University Of Queensland Flavivirus Replicon Constructs for Tumor Therapy
AU2006220887B2 (en) * 2005-03-04 2010-11-04 The Rockefeller University Infectious, chimeric Hepatitis C Virus, methods of producing the same and methods of use thereof
US20060234348A1 (en) * 2005-04-13 2006-10-19 Bujarski Jozef J Method of production of RNA polymerase protein
JP2007312649A (ja) * 2006-05-24 2007-12-06 Japan Health Science Foundation 再構築された感染性レトロウイルスゲノムクローンｄｎａ及びそれを含む微生物ならびにそれらの製造方法
AU2015234338C1 (en) * 2006-07-28 2017-07-20 The Trustees Of The University Of Pennsylvania Improved vaccines and methods for using the same
US7504255B2 (en) * 2006-08-17 2009-03-17 Saint Louis University Compositions and methods for generation of infectious hepatitis C virus in immortalized human hepatocytes
US20080096274A1 (en) * 2006-10-24 2008-04-24 Guangpu Li Recombinant alphavirus vectors and methods of using same
US9234181B2 (en) * 2007-11-26 2016-01-12 Novartis Ag RNA expression cassette and cells for making alphavirus particles
US8921536B2 (en) 2008-10-29 2014-12-30 The Trustees Of The University Of Pennsylvania HCV vaccines and methods for using the same
KR101609233B1 (ko) 2008-10-29 2016-04-05 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 개량된 ｈｃｖ 백신 및 이를 이용하는 방법
US20100129902A1 (en) * 2008-11-24 2010-05-27 Erhard Ralf Schoenbrunner Replication Stable and RNase Resistant Chimeras of Pestivirus with Insertion in 3' Nontranslated Region (3'NTR)
JPWO2011024875A1 (ja) * 2009-08-28 2013-01-31 公益財団法人東京都医学総合研究所 Ｃ型肝炎ウイルスの新規株由来のポリヌクレオチド及びその利用
US20110070199A1 (en) * 2009-09-21 2011-03-24 Scheiber Ii Lane Bernard Adaptable modified virus vector to deliver ribosomal ribonucleic acid combined with messenger ribonucleic acid as a medical treatment device to manage diabetes mellitus and other protein deficient dieases
EP2705150B1 (en) 2011-05-02 2020-07-29 The Johns Hopkins University A synthetic hepatitis c genome and methods of making and use
WO2013026054A2 (en) * 2011-08-18 2013-02-21 Axella Solutions, Llc Production of infectious rna viruses in yeast
CA2962696A1 (en) 2014-10-01 2016-04-07 National Research Council Of Canada Animal models, cell lines and methods for screening hepatitis c virus vaccines

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4631211A (en) * 1985-03-25 1986-12-23 Scripps Clinic & Research Foundation Means for sequential solid phase organic synthesis and methods using the same
US5218099A (en) * 1986-04-01 1993-06-08 The United States Of America As Represented By The Department Of Health And Human Services Post-transfusion, non-A, non-B hepatitis virus polynucleotides
EP0251575B2 (en) * 1986-06-17 2002-11-13 Chiron Corporation Hepatitis delta diagnostics and vaccines, their preparation and use
US5656731A (en) * 1987-10-15 1997-08-12 Chiron Corporation Nucleic acid-amplified immunoassay probes
US5679342A (en) * 1987-11-18 1997-10-21 Chiron Corporation Hepatitis C virus infected cell systems
US5714596A (en) * 1987-11-18 1998-02-03 Chiron Corporation NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
US5683864A (en) * 1987-11-18 1997-11-04 Chiron Corporation Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
WO1989004669A1 (en) * 1987-11-18 1989-06-01 Chiron Corporation Nanbv diagnostics and vaccines
US5712088A (en) * 1987-11-18 1998-01-27 Chiron Corporation Methods for detecting Hepatitis C virus using polynucleotides specific for same
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
YU48038B (sh) * 1987-11-18 1996-10-18 Chiron Corp. Postupak za dijagnostiku ne-a, ne-v hepatitisa
US5698390A (en) * 1987-11-18 1997-12-16 Chiron Corporation Hepatitis C immunoassays
US5312737A (en) * 1988-03-11 1994-05-17 Abbott Laboratories CKS method of HCV protein synthesis
US5010175A (en) * 1988-05-02 1991-04-23 The Regents Of The University Of California General method for producing and selecting peptides with specific properties
US5191064A (en) * 1988-09-30 1993-03-02 The Research Foundation For Microbial Diseases (Osaka University) Non-a, non-b hepatitis virus antigen peptide
JPH02167081A (ja) * 1988-12-21 1990-06-27 Tetsuo Nakamura 非Ａ非Ｂ型肝炎ウイルスゲノムＲＮＡ、ｃＤＮＡおよびウイルス抗原蛋白質
US5176994A (en) * 1988-12-21 1993-01-05 Immuno Japan Inc. Non-A, Non-B hepatitis virus genome RNA, cDNA and virus antigen protein
US5354844A (en) * 1989-03-16 1994-10-11 Boehringer Ingelheim International Gmbh Protein-polycation conjugates
WO1990011089A1 (en) * 1989-03-17 1990-10-04 Chiron Corporation Nanbv diagnostics and vaccines
ES2110411T3 (es) * 1989-08-25 1998-02-16 Chiron Corp Metodos para cultivar el virus de la hepatitis c (hcv) en lineas celulares de linfocitos b o t.
US5372928A (en) * 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV
KR940000755B1 (ko) * 1990-02-16 1994-01-29 유나이티드 바이오메디칼 인코오포레이티드 Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드
US5371017A (en) * 1990-04-04 1994-12-06 Chiron Corporation Hepatitis C virus protease
RO109916B1 (ro) * 1990-04-04 1995-07-28 Chiron Corp Compozitie de antigeni ai hepatitei virale c
EP1018558A3 (en) * 1990-04-06 2002-06-05 Genelabs Technologies, Inc. Hepatitis C Virus Epitopes
US5620843A (en) * 1990-06-30 1997-04-15 Akzo Nobel N.V. Non-A non-B sequences
KR0181517B1 (ko) * 1990-07-09 1999-04-01 나까하라 노부유끼 비-에이 비-비형 간염-특이 항원 및 간염 진단에서 그의 용도
HU227498B1 (en) * 1990-11-08 2011-07-28 Novartis Vaccines & Diagnostic Process for production of hepatitis c virus asialoglycoproteins
US5654179A (en) * 1990-11-14 1997-08-05 Hri Research, Inc. Nucleic acid preparation methods
EP0510952A1 (en) * 1991-04-26 1992-10-28 Immuno Japan Inc. Oligonucleotide primers and their application for high-fidelity detection of non-a, non-b hepatitis virus
WO1992022655A1 (en) * 1991-06-10 1992-12-23 Lucky Limited Hepatitis c diagnostics and vaccines
DE69232871T2 (de) * 1991-06-24 2003-05-08 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Polypeptide des hepatitis c-virus (hiv)
ATE172500T1 (de) * 1991-07-31 1998-11-15 Hoffmann La Roche Verfahren und reagenzien zur bestimmung von bakterien in der zerebrospinalen flüssigkeit
US5428145A (en) * 1991-08-09 1995-06-27 Immuno Japan, Inc. Non-A, non-B, hepatitis virus genome, polynucleotides, polypeptides, antigen, antibody and detection systems
ATE161291T1 (de) * 1991-08-27 1998-01-15 Hoffmann La Roche Verfahren und reagenzien zum nachweis von hepatitis c
US5427909A (en) * 1991-09-09 1995-06-27 Immuno Japan Inc. Oligonucleotides and determination system of HCV genotypes
EP0608261B1 (en) * 1991-09-13 2002-11-27 Chiron Corporation Immunoreactive hepatitis c virus polypeptide compositions
US5576302A (en) * 1991-10-15 1996-11-19 Isis Pharmaceuticals, Inc. Oligonucleotides for modulating hepatitis C virus having phosphorothioate linkages of high chiral purity
EP0627000B1 (en) * 1992-01-31 2003-10-29 Abbott Laboratories Mammalian expression systems for hcv proteins
JPH06105690A (ja) * 1992-03-10 1994-04-19 Kunitada Shimotoono 血液伝播性非ａ非ｂ型肝炎ウィルスｄｎａ
US5643578A (en) * 1992-03-23 1997-07-01 University Of Massachusetts Medical Center Immunization by inoculation of DNA transcription unit
US5610054A (en) * 1992-05-14 1997-03-11 Ribozyme Pharmaceuticals, Inc. Enzymatic RNA molecule targeted against Hepatitis C virus
US5552310A (en) * 1992-06-12 1996-09-03 Hiroshi Yoshikura Replication of hepatitis C virus genome and identification of virus having high infectivity
JP2778886B2 (ja) * 1992-10-16 1998-07-23 エバーニュー バイオテック インコーポレイティド Ｃ型肝炎ウィルスのコア抗原タンパク質及びそれを用いての診断方法及びキット
JPH06153961A (ja) * 1992-11-27 1994-06-03 Imuno Japan:Kk Ｃ型肝炎ウイルス部分遺伝子、ならびにｃ型肝炎ウイルス遺 伝子の高感度検出法
AU6364094A (en) * 1993-03-12 1994-09-26 Board Of Regents, The University Of Texas System Anthracyclines with unusually high activity against cells resistant to doxorubicin and its analogs
TW275068B (enExample) * 1993-09-24 1996-05-01 American Cyanamid Co
ATE475668T1 (de) * 1994-01-27 2010-08-15 Univ Massachusetts Medical Immunisierung durch impfung von dns transkriptionseinheit
US5861267A (en) * 1995-05-01 1999-01-19 Vertex Pharmaceuticals Incorporated Methods, nucleotide sequences and host cells for assaying exogenous and endogenous protease activity
US5874565A (en) * 1995-08-29 1999-02-23 Washington University Nucleic acids comprising a highly conserved novel 3 terminal sequence element of the hepatitis C virus
US5677124A (en) * 1996-07-03 1997-10-14 Ambion, Inc. Ribonuclease resistant viral RNA standards
US6153421A (en) * 1997-07-18 2000-11-28 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Cloned genomes of infectious hepatitis C viruses and uses thereof

Similar Documents

Publication Publication Date Title
JP2001526857A5 (enExample)
JP2000510751A5 (enExample)
JP2000509635A5 (enExample)
JP2000507042A5 (enExample)
JP2000509637A5 (enExample)
JP2000509942A5 (enExample)
JP2000509912A5 (enExample)
JP2001515356A5 (enExample)
JP2002511917A5 (enExample)
JP2001521447A5 (enExample)
JP2000507369A5 (enExample)
JP2001515353A5 (enExample)
JP2000507433A5 (enExample)
JP2000508866A5 (enExample)
JP2000510793A5 (enExample)
JP2000508022A5 (enExample)
JP2002510343A5 (enExample)
JP2002505058A5 (enExample)
JP2000509804A5 (enExample)
JP2001518150A5 (enExample)
JP2000509853A5 (enExample)
JP2000509755A5 (enExample)
JP2000510969A5 (enExample)
JP2000510247A5 (enExample)
JP2000508102A5 (enExample)